Literature DB >> 16715292

The association between total antioxidant status and oxidative stress in Behçet's disease.

Aylin Sepici-Dinçel1, Yeşim Ozkan, Sevgi Yardim-Akaydin, Gülçin Kaymak-Karataş, Meltem Onder, Bolkan Simşek.   

Abstract

There has recently been growing evidence supporting the importance of oxidative stress in the pathogenesis of Behçet's disease (BD). In this study, we aim to evaluate total antioxidant status (TAS) and total oxidative stress (TOS) in BD patients, and compare their results both with controls that had recurrent aphthous stomatitis (RAS) and healthy controls. TAS statistically decreased in RAS patients, and TOS levels increased in BD and RAS patients than those in healthy controls. The serum levels of Cu significantly increased only in BD patients when compared with healthy controls. Fe levels were not statistically different among the BD patients, RAS patients and healthy controls, but there was a positive correlation between TOS and plasma Fe levels in BD patients. Our results suggest that there is an insufficient antioxidant system and increased oxidative status both in BD and RAS patients. The antioxidant supplementations in addition to medical treatments will improve the quality of life.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16715292     DOI: 10.1007/s00296-006-0126-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

Review 1.  Biomarkers of oxidative stress: an analytical approach.

Authors:  P Thérond; D Bonnefont-Rousselot; A Davit-Spraul; M Conti; A Legrand
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2000-09       Impact factor: 4.294

Review 2.  Methodologies for evaluation of total antioxidant activities in complex mixtures. A critical review.

Authors:  S Llesuy; P Evelson; A M Campos; E Lissi
Journal:  Biol Res       Date:  2001       Impact factor: 5.612

Review 3.  Phagocytes and oxidative stress.

Authors:  B M Babior
Journal:  Am J Med       Date:  2000-07       Impact factor: 4.965

Review 4.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

Authors:  Barry Halliwell; Matthew Whiteman
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

Review 5.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

6.  Evaluation of nitrosative and oxidative stress in Behçet disease.

Authors:  S Bekpinar; N Kiliç; Y Unlüçerçi; A Akdag-Köse; G Azizlerli; Z Ozbek-Kir
Journal:  J Eur Acad Dermatol Venereol       Date:  2005-03       Impact factor: 6.166

7.  Increased advanced oxidation protein products in Behçet's disease: a new activity marker?

Authors:  C Yazici; K Köse; M Caliş; M DemIr; M Kirnap; F Ateş
Journal:  Br J Dermatol       Date:  2004-07       Impact factor: 9.302

8.  The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet's disease.

Authors:  Asim Orem; Y Emre Yandi; Birgül Vanizor; Gülseren Cimşit; Hüseyin Avni Uydu; Meltem Malkoç
Journal:  Clin Biochem       Date:  2002-05       Impact factor: 3.281

9.  Evaluation of allantoin levels as a new marker of oxidative stress in Behçet's disease.

Authors:  S Yardim-Akaydin; A Sepici; Y Ozkan; B Simşek; V Sepici
Journal:  Scand J Rheumatol       Date:  2006 Jan-Feb       Impact factor: 3.641

Review 10.  Joint manifestations in Behçet's disease. A review of 340 cases.

Authors:  S Benamour; B Zeroual; F Z Alaoui
Journal:  Rev Rhum Engl Ed       Date:  1998-05
View more
  9 in total

1.  DNA damage and its relationship with other oxidative stress parameters in Behcet's disease.

Authors:  E D Sezer; K Aksu; O Caglayan; G Keser; G Karabulut; G Ercan
Journal:  Rheumatol Int       Date:  2010-09-14       Impact factor: 2.631

Review 2.  Epidemiology and management of neuropsychiatric disorders in Behçet's syndrome.

Authors:  Rosaria Talarico; Laura Palagini; Anna d'Ascanio; Elena Elefante; Claudia Ferrari; Chiara Stagnaro; Chiara Tani; Angelo Gemignani; Mauro Mauri; Stefano Bombardieri; Marta Mosca
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749

3.  Pomegranate juice may be a potential addition to anti-Behçet armamentarium: a hypothesis.

Authors:  Afshin Borhani Haghighi; Mansooreh Bagheri
Journal:  Clin Rheumatol       Date:  2007-04-04       Impact factor: 2.980

4.  Serum levels of natriuretic peptides in patients with Behcet's disease.

Authors:  Ramazan Yağci; Yüksel Totan; Ekin Ozlük; Hüseyin Ozyurt; Gülfer Akbay; Meral Ekşioğlu
Journal:  Clin Rheumatol       Date:  2008-04-15       Impact factor: 2.980

5.  Thiol/disulfide homeostasis in patients with ocular-active and ocular-inactive Behçet disease.

Authors:  Mehmet Balbaba; Fatih Ulaş; Hakan Yıldırım; Adem Soydan; Ali Dal; Süleyman Aydın
Journal:  Int Ophthalmol       Date:  2020-06-01       Impact factor: 2.031

6.  Serum prolidase enzyme activity and oxidative status in patients with Behçet's disease.

Authors:  Mehtap Bozkurt; Hatice Yüksel; Serda Em; Pelin Oktayoglu; Mehmet Yildiz; Dicle Akdeniz; Kemal Nas
Journal:  Redox Rep       Date:  2013-11-12       Impact factor: 4.412

7.  Total serum oxidant/antioxidant status and arylesterase activity in recurrent aphthous stomatitis.

Authors:  Gulsen Akoglu; Ahmet Metin; Fadime Kilinc; Suzan Demir Pektas; Semra Isikoglu; Ayse Akbas; Sertac Sener
Journal:  Ann Dermatol       Date:  2013-08-13       Impact factor: 1.444

8.  Oxidative stress and cellular immunity in patients with recurrent aphthous ulcers.

Authors:  E Avci; Z Z Akarslan; H Erten; S Coskun-Cevher
Journal:  Braz J Med Biol Res       Date:  2014-05-02       Impact factor: 2.590

9.  Salivary Level of Trace Element in Oral Lichen Planus, A Premalignant Condition.

Authors:  Fahimeh Rezazadeh; Sadaf Salehi; Mostafa Rezaee
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.